Oddo Bhf Asset Management Sas Revance Therapeutics, Inc. Transaction History
Oddo Bhf Asset Management Sas
- $1.98 Trillion
- Q4 2024
A detailed history of Oddo Bhf Asset Management Sas transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Oddo Bhf Asset Management Sas holds 5,100,000 shares of RVNC stock, worth $13.1 Million. This represents 0.78% of its overall portfolio holdings.
Number of Shares
5,100,000
Previous 725,000
603.45%
Holding current value
$13.1 Million
Previous $3.76 Billion
312.04%
% of portfolio
0.78%
Previous 0.19%
Shares
2 transactions
Others Institutions Holding RVNC
# of Institutions
208Shares Held
80.9MCall Options Held
2.26MPut Options Held
5.48M-
Black Rock Inc. New York, NY8.57MShares$22 Million0.0% of portfolio
-
Beryl Capital Management LLC Redondo Beach, CA5.94MShares$15.3 Million9.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$14.5 Million0.0% of portfolio
-
Fil LTD Hamilton, D04.2MShares$10.8 Million0.01% of portfolio
-
Alliancebernstein L.P. New York, NY3.5MShares$8.99 Million0.0% of portfolio
About Revance Therapeutics, Inc.
- Ticker RVNC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,305,696
- Market Cap $212M
- Description
- Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...